Author: Oliver, Jane; Tosif, Shidan; Lee, Laiâ€yang; Costa, Annaâ€Maria; Bartel, Chelsea; Last, Katherine; Clifford, Vanessa; Daley, Andrew; Allard, Nicole; Orr, Catherine; Nind, Ashley; Alexander, Karyn; Meagher, Niamh; Sait, Michelle; Ballard, Susan A; Williams, Eloise; Bond, Katherine; Williamson, Deborah A; Crawford, Nigel W; Gibney, Katherine B
Title: Adding saliva testing to oropharyngeal and deep nasal swab testing increases PCR detection of SARSâ€CoVâ€2 in primary care and children Cord-id: ylqhlud2 Document date: 2021_7_20
ID: ylqhlud2
Snippet: OBJECTIVE: To compare the concordance and acceptability of saliva testing with standardâ€ofâ€care oropharyngeal and bilateral deep nasal swab testing for severe acute respiratory syndrome coronavirusâ€2 (SARSâ€CoVâ€2) in children and in general practice. DESIGN: Prospective multicentre diagnostic validation study. SETTING: Royal Children’s Hospital, and two general practices (cohealth, West Melbourne; Cirqit Health, Altona North) in Melbourne, July–October 2020. PARTICIPANTS: 1050 peopl
Document: OBJECTIVE: To compare the concordance and acceptability of saliva testing with standardâ€ofâ€care oropharyngeal and bilateral deep nasal swab testing for severe acute respiratory syndrome coronavirusâ€2 (SARSâ€CoVâ€2) in children and in general practice. DESIGN: Prospective multicentre diagnostic validation study. SETTING: Royal Children’s Hospital, and two general practices (cohealth, West Melbourne; Cirqit Health, Altona North) in Melbourne, July–October 2020. PARTICIPANTS: 1050 people who provided paired saliva and oropharyngealâ€nasal swabs for SARSâ€CoVâ€2 testing. MAIN OUTCOME MEASURES: Numbers of cases in which SARSâ€CoVâ€2 was detected in either specimen type by realâ€time polymerase chain reaction; concordance of results for paired specimens; positive percent agreement (PPA) for virus detection, by specimen type. RESULTS: SARSâ€CoVâ€2 was detected in 54 of 1050 people with assessable specimens (5%), including 19 cases (35%) in which both specimens were positive. The overall PPA was 72% (95% CI, 58–84%) for saliva and 63% (95% CI, 49–76%) for oropharyngealâ€nasal swabs. For the 35 positive specimens from people aged 10 years or more, PPA was 86% (95% CI, 70–95%) for saliva and 63% (95% CI, 45–79%) for oropharyngealâ€nasal swabs. Adding saliva testing to standardâ€ofâ€care oropharyngealâ€nasal swab testing increased overall case detection by 59% (95% CI, 29–95%). Providing saliva was preferred to an oropharyngealâ€nasal swab by most participants (75%), including 141 of 153 children under 10 years of age (92%). CONCLUSION: In children over 10 years of age and adults, saliva testing alone may be suitable for SARSâ€CoVâ€2 detection, while for children under 10, saliva testing may be suitable as an adjunct to oropharyngealâ€nasal swab testing for increasing case detection.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date